Clinical Trial Update: Proteomic Study of Chuanhong Zhongfeng Capsule in the Treatment of ACI [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the proteomic effects of Chuanhong Zhongfeng Capsule for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Chuanhong Zhongfeng Capsule

Snippet

Sponsor: Yingyue Ding | Conditions: Acute Ischemic Stroke | Phase 1 | Status: COMPLETED